- Investing Ideas
- /
- Bulgarian Pharmaceuticals & Biotech Potentially Undervalued Companies
Bulgarian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
12
Companies with a Value score of at least 3, ordered by Value score
12 companies
Bayer
Market Cap: €19.8b
Operates as a life science company worldwide.
BAYN
€20.75
7D
-6.5%
1Y
n/a
Teva Pharmaceutical Industries
Market Cap: €15.4b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEV
€12.70
7D
0%
1Y
n/a
Merck KGaA
Market Cap: €50.1b
Operates as a science and technology company in Germany.
MRK
€114.65
7D
0%
1Y
n/a
Merck
Market Cap: €199.2b
Operates as a healthcare company worldwide.
6MK
€68.10
7D
-16.3%
1Y
n/a
Sanofi
Market Cap: €109.7b
A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.
SNW
€93.76
7D
1.9%
1Y
n/a
Novo Nordisk
Market Cap: €1.9t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOV
€54.83
7D
-5.0%
1Y
n/a
Novavax
Market Cap: €942.5m
A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.
NVV1
€4.78
7D
0%
1Y
17.6%
Valneva
Market Cap: €450.5m
A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.
AYJ
€3.00
7D
0%
1Y
-25.4%
Evotec
Market Cap: €950.4m
Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.
EVT
€6.35
7D
0%
1Y
n/a
Pfizer
Market Cap: €124.3b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
€20.86
7D
2.5%
1Y
-14.7%
Tilray Brands
Market Cap: €1.5b
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.
2HQ
€1.58
7D
0%
1Y
n/a
Aurora Cannabis
Market Cap: €314.5m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
21P
€4.34
7D
0%
1Y
-31.4%